Melanie Herre
Impact in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune cells in cancer
- Immune Response and Inflammation
-
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Immune cells in cancer 3
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
- Inflammation biomarkers and pathways 1
-
- Fibroblast Growth Factor Research 2
- Co-authors
- Jessica Cedervall (4 shared papers)Anna‐Karin Olsson (4 shared papers)Nigel Mackman (1 shared paper)Yanyu Zhang (2 shared papers)Qi Qiao (2 shared papers)Anahita Hamidi (2 shared papers)Alessandra Vaccaro (1 shared paper)Anna Dimberg (1 shared paper)
- Journals
- Cancers (1 paper)Research and Practice in Thrombosis and Haemostasis (1 paper)Physiological Reviews (1 paper)Cancer Research (1 paper)FASEB BioAdvances (1 paper)
- Partner nations
- SwedenUnited StatesFinland
In The Last Decade
Melanie Herre
5 papers receiving 236 citations
Peers
Comparison fields: 5 of 47
- Immunology 118
- Internal Medicine 15
- Oncology 66
- Hematology 16
- Immunology and Allergy 8
Countries citing papers authored by Melanie Herre
This map shows the geographic impact of Melanie Herre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Herre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Herre more than expected).
Fields of papers citing papers by Melanie Herre
This network shows the impact of papers produced by Melanie Herre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Herre. The network helps show where Melanie Herre may publish in the future.
Co-authors
The 25 scholars most cited alongside Melanie Herre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 145 | |
| 2 | 2020 | 66 | |
| 3 | 2022 | 24 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 1 |
About Melanie Herre
Melanie Herre is a scholar working on Immunology, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Hematology, having authored 5 papers that have together received 239 indexed citations. Recurring topics across this work include Immune cells in cancer (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Fibroblast Growth Factor Research (2 papers), Proteoglycans and glycosaminoglycans research (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper), Inflammation biomarkers and pathways (1 paper) and Neonatal Respiratory Health Research (1 paper). The work is most often cited by research in Immunology (118 citations), Internal Medicine (15 citations), Oncology (66 citations), Hematology (16 citations) and Immunology and Allergy (8 citations). Melanie Herre has collaborated with scholars based in Sweden, United States and Finland. Frequent co-authors include Jessica Cedervall, Anna‐Karin Olsson, Nigel Mackman, Yanyu Zhang, Qi Qiao, Anahita Hamidi, Alessandra Vaccaro, Anna Dimberg, Christer Betsholtz and Johanna Andræ. Their work appears in journals such as Cancers, Research and Practice in Thrombosis and Haemostasis, Physiological Reviews, Cancer Research and FASEB BioAdvances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.